A detailed history of Seaview Investment Managers LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Seaview Investment Managers LLC holds 10,042 shares of LLY stock, worth $7.71 Million. This represents 2.7% of its overall portfolio holdings.

Number of Shares
10,042
Previous 10,487 4.24%
Holding current value
$7.71 Million
Previous $9.49 Million 6.3%
% of portfolio
2.7%
Previous 2.87%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$772.14 - $960.02 $343,602 - $427,208
-445 Reduced 4.24%
10,042 $8.9 Million
Q2 2024

Aug 07, 2024

BUY
$724.87 - $909.04 $7.6 Million - $9.53 Million
10,487 New
10,487 $9.49 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Seaview Investment Managers LLC Portfolio

Follow Seaview Investment Managers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seaview Investment Managers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Seaview Investment Managers LLC with notifications on news.